Citations

Clear

3942 citation(s) found for "To, Van".

Natural history and clinical detection of undiagnosed coeliac disease in a North American community
Hujoel, Isabel A. , Dyke, Carol T. Van, Brantner, Tricia L., Larson, Joseph J. , Sharma, Ayush , Murray, Joseph A. , Hujoel, I A , Sharma, A , Murray, J A , King, Katherine S. , Rubio‐Tapia, Alberto

Mayo Clinic

Alimentary Pharmacology & Therapeutics | March 26, 2018 | Volume: 47 | Issue: 10 | Pages: 1358-1366

10.1111/apt.14625 | PMID 29577349 Get It

SummaryBackgroundCoeliac disease is a substantially underdiagnosed disorder, with clinical testing currently guided by case finding.AimTo determine the presence of indications for diagnostic testing and frequency of clinical testing in undiagnosed coeliac disease.MethodsThis was a case‐control study of adults without prior diagnosis of coeliac disease. Undiagnosed cases were identified through sequential serology, and unaffected age‐ and gender‐matched controls were selected. Medical records were systematically reviewed for indications for and evidence of clinical testing.ResultsOf 47 557 adults, 408 cases of undiagnosed coeliac disease were identified. 408 serology negative matched controls were selected. Eight‐matched pairs were excluded, leading to 800 included individuals (61% female; median age 44.2 years). The odds of any indication for clinical testing were similar among undiagnosed coeliac disease and controls (odds ratio (OR) 1.18; 95% CI: 0.85‐1.63, P = 0.32). Most individual indications were not associated with serologic status. Exceptions to this include hypothyroidism, which was more likely in cases of undiagnosed coeliac disease, and dyspepsia and chronic diarrhoea, which were less likely. Cases of undiagnosed coeliac disease were more likely to develop osteoporosis (P = 0.005), dermatitis herpetiformis (P = 0.006), chronic fatigue (P = 0.033), thyroiditis (P = 0.003), autoimmune diseases (P = 0.008), and have a family member diagnosed with coeliac disease (P = 0.001).ConclusionThis study strongly suggests that current case finding is not effective in detecting undiagnosed coeliac disease. Individuals with undiagnosed coeliac disease were more likely than controls to develop indications for testing overtime. A more effective method for detection of coeliac disease is needed.
Curriculum for neurogastroenterology and motility training: A report from the joint ANMS ‐ ESNM task force
Gyawali, C. Prakash , Savarino, Edoardo , Lazarescu, Adriana , Patel, Amit , Pressman, Amanda, Drewes, Asbjørn Mohr , Rosen, John M. , Saps, Miguel , Novais, L., Vázquez‐Roque, María I. , Pohl, Daniel , Tilburg, Miranda A.L. van , Smout, A. J. P. M. , Yoon, Sang-Moon, Pandolfino, John E. , Farrugia, Gianrico , Barbara, Giovanni , Roman, Sabine , Gyawali, C P , Patel, A , Roman, S , Savarino, Edoardo , Bor, Serhat , Dickman, Ram M. , Drug, Vasile Liviu , Yoon, S.

Mayo Clinic

Neurogastroenterology & Motility | March 26, 2018 | Volume: 30 | Issue: 9 | Pages: No page available

10.1111/nmo.13341 | PMID 29577508 Get It

Abstract Although neurogastroenterology and motility ( NGM ) disorders are some of the most frequent disorders encountered by practicing gastroenterologists, a structured competency‐based training curriculum developed by NGM experts is lacking. The American Neurogastroenterology and Motility Society ( ANMS ) and the European Society of Neurogastroenterology and Motility ( ESNM ) jointly evaluated the components of NGM training in North America and Europe. Eleven training domains were identified within NGM , consisting of functional gastrointestinal disorders, visceral hypersensitivity and pain pathways, motor disorders within anatomic areas (esophagus, stomach, small bowel and colon, anorectum), mucosal disorders (gastro‐esophageal reflux disease, other mucosal disorders), consequences of systemic disease, consequences of therapy (surgery, endoscopic intervention, medications, other therapy), and transition of pediatric patients into adult practice. A 3‐tiered training curriculum covering these domains is proposed here and endorsed by all NGM societies. Tier 1 NGM knowledge and training is expected of all gastroenterology trainees and practicing gastroenterologists. Tier 2 knowledge and training is appropriate for trainees who anticipate NGM disorder management and NGM function test interpretation being an important part of their careers, which may require competency assessment and credentialing of test interpretation skills. Tier 3 knowledge and training is undertaken by trainees interested in a dedicated NGM career and may be restricted to specific domains within the broad NGM field. The joint ANMS and ESNM task force anticipates that the NGM curriculum will streamline NGM training in North America and Europe and will lead to better identification of centers of excellence where Tier 2 and Tier 3 training can be accomplished.
Exercise on‐transition uncoupling of ventilatory, gas exchange and cardiac hemodynamic kinetics accompany pulmonary oxygen stores depletion to impact exercise intolerance in human heart failure
Iterson, Erik H. Van , Smith, Joshua R. , Olson, Thomas P. , Van Iterson, Erik H , Smith, Joshua R

Mayo Clinic

Acta Physiologica | March 25, 2018 | Volume: 223 | Issue: 4 | Pages: No page available

10.1111/apha.13063 | PMID 29575588 Get It

AbstractAimIn contrast to knowledge that heart failure (HF) patients demonstrate peak exercise uncoupling across ventilation, gas exchange and cardiac haemodynamics, whether this dyssynchrony follows that at the exercise on‐transition is unclear. This study tested whether exercise on‐transition temporal lag for ventilation relative to gas exchange and oxygen pulse (O2pulse) couples with effects from abnormal pulmonary gaseous oxygen store (O2store) contributions to O2 to interdependently precipitate persistently elevated ventilatory demand and low oxidative metabolic capacity in HF.MethodsBeat‐to‐beat HR and breath‐to‐breath ventilation and gas exchange were continuously acquired in HF (N = 9, ejection fraction = 30 ± 9%) and matched controls (N = 10) during square‐wave ergometry at 60% O2peak (46 ± 14 vs 125 ± 54‐W, P < .001). Temporal responses across E, O2 and O2pulse were assessed for the exercise on‐transition using single exponential model Phase II on‐kinetic time constants (τ = time to reach 63% steady‐state rise). Breath‐to‐breath gas fractions and respiratory flows were used to determine O2stores.ResultsHF vs controls: τ for E (137 ± 93 vs 74 ± 40‐seconds, P = .03), O2 (60 ± 40 vs 23 ± 5‐seconds, P = .03) and O2pulse (28 ± 18 vs 23 ± 15‐seconds, P = .59). Within HF, τ for E differed from O2pulse (P < .02), but not O2. Exercise E rise (workload indexed) differed in HF vs controls (545 ± 139 vs 309 ± 88‐mL min−1 W−1, P < .001). Exercise on‐transition O2store depletion in HF exceeded controls, generally persisting to end‐exercise.ConclusionThese data suggest HF demonstrated exercise on‐transition O2store depletion (high O2store contribution to O2) coupled with dyssynchronous E, O2 and O2pulse kinetics—not attributable to prolonged cardiac haemodynamics. Persistent high ventilatory demand and low oxidative metabolic capacity in HF may be precipitated by physiological uncoupling occurring within the exercise on‐transition.
A rapid and reliable chromosome analysis method for products of conception using interphase nuclei
Babu, Ramesh , Dyke, Daniel L. Van , Bhattacharya, Saurabh Kumar , Dev, Vaithilingam G., Liu, Mingya, Kwon, Minjae, Gu, Guangyu , Koduru, Prasad , Rao, Nagesh, Williamson, Cynthia M., Fuentes, Sarah, Papa, Stephen, Kopuri, Srikanthi, Lal, Vandana , Van Dyke, Daniel L, Williamson, Cynthia, Fuentes, Ernesto J.

Mayo Clinic

Molecular Genetics & Genomic Medicine | March 24, 2018 | Volume: 6 | Issue: 3 | Pages: 370-381

10.1002/mgg3.381 | PMID 29573570 Get It

AbstractBackgroundKaryotype determination has a central role in the genetic workup of pregnancy loss, as aneuploidy (trisomy and monosomy) and polyploidy (triploidy and tetraploidy) are the cause in at least 50% of first trimester, 25% of second trimester, and 11% of third trimester miscarriages. There are several limitations with the current approaches of obtaining a karyotype using traditional cytogenetics, fluorescence in situ hybridization with a limited number of probes, and chromosomal microarray. These include culture failure, incomplete results, lower sensitivity, and longer reporting time.MethodsTo overcome current limitations, a novel molecular assay is developed with a Standard Resolution Interphase Chromosome Profiling probe set which is a variation of the recently developed High Resolution probe set. It generates a molecular karyotype that can detect all major changes commonly associated with pregnancy loss. Initial familiarization of signal patterns from the probe set was used, followed by validation of the method using 83 samples from miscarriages in a blind study from three different laboratories. Finally, the clinical utility of the method was tested on 291 clinical samples in two commercial reference laboratory settings on two different continents.ResultsThe new molecular approach not only identified all the chromosome changes observed by current methods, but also significantly improved abnormality detection by characterizing derivative chromosomes and finding subtle subtelomeric rearrangements, balanced and unbalanced. All Robertsonian translocations were also detected. The abnormality rate was 54% on clinical samples from commercial laboratory 1 and 63% from laboratory 2.ConclusionThe attributes of this method make it an ideal choice for the genetic workup of miscarriages, namely (1) near 100% successful results, (2) greater sensitivity than conventional chromosome analysis or FISH panels, (3) rapid reporting time, and (4) favorable comparisons with chromosomal microarray.
The COMMD Family Regulates Plasma LDL Levels and Attenuates Atherosclerosis Through Stabilizing the CCC Complex in Endosomal LDLR Trafficking
Fedoseienko, Alina , Wijers, Melinde, Wolters, Justina C. , Dekker, Daphne, Smit, Marieke , Huijkman, Nicolette, Kloosterhuis, Niels , Klug, Helene, Schepers, Aloys , Levels, J.H.M. , Billadeau, Daniel D. , Hofker, Marten H., Deursen, Jan van, Westerterp, Marit , Kuivenhoven, Jan Albert , Sluis, Bart van de , van Deursen, Jan, Burstein, Ezra , van de Sluis, Bart , Dijk, Ko Willems van

Mayo Clinic

Circulation Research | March 15, 2018 | Volume: 122 | Issue: 12 | Pages: 1648-1660

10.1161/circresaha.117.312004 | PMID 29545368 Get It

Rationale: COMMD (copper metabolism MURR1 domain)-containing proteins are a part of the CCC (COMMD–CCDC22 [coiled-coil domain containing 22]–CCDC93 [coiled-coil domain containing 93]) complex facilitating endosomal trafficking of cell surface receptors. Hepatic COMMD1 inactivation decreases CCDC22 and CCDC93 protein levels, impairs the recycling of the LDLR (low-density lipoprotein receptor), and increases plasma low-density lipoprotein cholesterol levels in mice. However, whether any of the other COMMD members function similarly as COMMD1 and whether perturbation in the CCC complex promotes atherogenesis remain unclear. Objective: The main aim of this study is to unravel the contribution of evolutionarily conserved COMMD proteins to plasma lipoprotein levels and atherogenesis. Methods and Results: Using liver-specific Commd1 , Commd6 , or Commd9 knockout mice, we investigated the relation between the COMMD proteins in the regulation of plasma cholesterol levels. Combining biochemical and quantitative targeted proteomic approaches, we found that hepatic COMMD1, COMMD6, or COMMD9 deficiency resulted in massive reduction in the protein levels of all 10 COMMDs. This decrease in COMMD protein levels coincided with destabilizing of the core (CCDC22, CCDC93, and chromosome 16 open reading frame 62 [C16orf62]) of the CCC complex, reduced cell surface levels of LDLR and LRP1 (LDLR-related protein 1), followed by increased plasma low-density lipoprotein cholesterol levels. To assess the direct contribution of the CCC core in the regulation of plasma cholesterol levels, Ccdc22 was deleted in mouse livers via CRISPR/Cas9-mediated somatic gene editing. CCDC22 deficiency also destabilized the complete CCC complex and resulted in elevated plasma low-density lipoprotein cholesterol levels. Finally, we found that hepatic disruption of the CCC complex exacerbates dyslipidemia and atherosclerosis in ApoE3*Leiden mice. Conclusions: Collectively, these findings demonstrate a strong interrelationship between COMMD proteins and the core of the CCC complex in endosomal LDLR trafficking. Hepatic disruption of either of these CCC components causes hypercholesterolemia and exacerbates atherosclerosis. Our results indicate that not only COMMD1 but all other COMMDs and CCC components may be potential targets for modulating plasma lipid levels in humans.
Prognostic factors for human papillomavirus–positive and negative oropharyngeal carcinomas
Yin, Linda X. , DʼSouza, Gypsyamber , Westra, William H. , Wang, Steven J. , Zante, Annemieke van , Zhang, Yuehan , Rettig, Eleni M. , Ryan, William R. , Ha, Patrick K. , Wentz, Alicia, Koch, Wayne M. , Eisele, David W. , Fakhry, Carole , Koch, Wayne , Yin, Linda X

Mayo Clinic

The Laryngoscope | March 15, 2018 | Volume: 128 | Issue: 8 | Pages: No page available

10.1002/lary.27130 | PMID 29536542 Get It

Objectives/HypothesisHuman papillomavirus (HPV)‐positive and HPV‐negative oropharyngeal squamous cell carcinoma (OPSCC) are distinct disease entities. Prognostic factors specific to each entity have not been adequately explored. Goals for this study were: 1) to determine whether HPV‐positive and HPV‐negative OPSCCs have distinct prognostic factors, and 2) to explore the prognostic significance of sex and race in OPSCC after HPV stratificationStudy DesignRetrospective case series.MethodsA retrospective review of 239 incident OPSCC patients from 1995 to 2012, treated at Johns Hopkins and University of California–San Francisco was conducted. Women and nonwhite races were oversampled. All analyses were stratified by tumor HPV in situ hybridization status. The effects of sex and race on survival were considered in Kaplan‐Meier and unadjusted and adjusted Cox regression models.ResultsOne hundred thirty‐four (56.1%) OPSCC patients were HPV positive. On univariate analysis, women had better overall survival than men among HPV‐positive (hazard ratio [HR]: 0.47, 95% confidence interval [CI]: 0.20‐1.07; P = .06) but not HPV‐negative (HR: 0.73, 95% CI: 0.43‐1.24; P = .24) OPSCCs. On multivariate analysis, women with HPV‐positive OPSCCs remained at lower risk of death (adjusted hazard ratio [aHR]: 0.34, 95% CI: 0.12‐0.96; P = .04). Survival did not vary significantly by race among HPV‐positive patients. Among HPV‐negative patients, Hispanic patients had significantly better survival in unadjusted (HR: 0.27, 95% CI: 0.08‐0.91; P = .04) but not adjusted (aHR: 0.93, 95% CI: 0.11‐7.36; P = .94) analysis.ConclusionsWomen with HPV‐positive OPSCC may have improved overall survival compared to men. Sex does not play a prognostic role in HPV‐negative OPSCC. There are no differences in prognosis by race among HPV‐positive or HPV‐negative patients.Level of Evidence4 Laryngoscope, E288–E296, 2018
Lightweight, compact, and high‐performance 3T MR system for imaging the brain and extremities
Foo, Thomas , Laskaris, E.T., Vermilyea, Mark, Xu, Minfeng , Thompson, Paul, Conte, Gene, Epps, Christopher Van, Immer, Christopher, Tan, Ek T. , Graziani, Dominic, Mathieu, Jean‐Baptise, Hardy, Christopher J., Schenck, John F., Fiveland, Eric, Stautner, Wolfgang , Ricci, Justin, Piel, Joseph E., Park, Keith, Hua, Yihe , Bai, Ye , Kagan, Alex, Stanley, David A. , Weavers, Paul T., Gray, Erin M. , Shu, Yunhong , Frick, Matthew A., Trzasko, Joshua D. , Foo, Thomas K F , Tan, Ek T , Gray, Erin, Trzasko, Joshua, Bernstein, Matt A , Thompson, Paul, Epps, Chris Van, Lee, Seung‐Kyun , Campeau, Norbert G. , Huston, John , Bernstein, Matt A.

Mayo Clinic

Magnetic Resonance in Medicine | March 15, 2018 | Volume: 80 | Issue: 5 | Pages: 2232-2245

10.1002/mrm.27175 | PMID 29536587 Get It

PurposeTo build and evaluate a small‐footprint, lightweight, high‐performance 3T MRI scanner for advanced brain imaging with image quality that is equal to or better than conventional whole‐body clinical 3T MRI scanners, while achieving substantial reductions in installation costs.MethodsA conduction‐cooled magnet was developed that uses less than 12 liters of liquid helium in a gas‐charged sealed system, and standard NbTi wire, and weighs approximately 2000 kg. A 42‐cm inner‐diameter gradient coil with asymmetric transverse axes was developed to provide patient access for head and extremity exams, while minimizing magnet‐gradient interactions that adversely affect image quality. The gradient coil was designed to achieve simultaneous operation of 80‐mT/m peak gradient amplitude at a slew rate of 700 T/m/s on each gradient axis using readily available 1‐MVA gradient drivers.ResultsIn a comparison of anatomical imaging in 16 patients using T2‐weighted 3D fluid‐attenuated inversion recovery (FLAIR) between the compact 3T and whole‐body 3T, image quality was assessed as equivalent to or better across several metrics. The ability to fully use a high slew rate of 700 T/m/s simultaneously with 80‐mT/m maximum gradient amplitude resulted in improvements in image quality across EPI, DWI, and anatomical imaging of the brain.ConclusionsThe compact 3T MRI system has been in continuous operation at the Mayo Clinic since March 2016. To date, over 200 patient studies have been completed, including 96 comparison studies with a clinical 3T whole‐body MRI. The increased gradient performance has reliably resulted in consistently improved image quality.
Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR
Daikh, David, Betteridge, Neil , Burmester, Gerd R , Hassett, Afton L. , Matteson, Eric L. , Vollenhoven, Ronald van , Lakhanpal, Sharad, Heijde, Désirée M F M van der , Burmester, Gerd-Rüdiger

Mayo Clinic

Arthritis & Rheumatology | March 15, 2018 | Volume: 70 | Issue: 6 | Pages: 826-831

10.1002/art.40448 | PMID 29532625 Get It

A European League Against Rheumatism–American College of Rheumatology working group consisting of practicing and academic rheumatologists, a rheumatology researcher, and a patient representative created a succinct general statement describing rheumatic and musculoskeletal diseases (RMDs) in adults and children in language that can be used in conversations with the lay public, media, healthcare providers, and other stakeholders. Based on the literature review, several elements were deemed important for inclusion in the description of RMDs. First, RMDs encompass many different diseases that can affect individuals at any age, including children. Second, there are various pathophysiological pathways underlying different RMDs. Third, the impact of RMDs on individuals and society should be emphasized. The working group agreed that the language should be comprehensible to the lay public. Thus, the following description of RMDs has been developed: “Rheumatic and musculoskeletal diseases (RMDs) are a diverse group of diseases that commonly affect the joints, but can affect any organ of the body. There are more than 200 different RMDs, affecting both children and adults. They are usually caused by problems of the immune system, inflammation, infections, or gradual deterioration of joints, muscles, and bones. Many of these diseases are long term and worsen over time. They are typically painful and limit function. In severe cases, RMDs can result in significant disability, having a major impact on both quality of life and life expectancy.” This description can be used by rheumatology groups, researchers, and those who work in advocacy and education related to RMDs.
Patient Acceptance of Sexual Orientation and Gender Identity Questions on Intake Forms in Outpatient Clinics: A Pragmatic Randomized Multisite Trial
Rullo, Jordan , Foxen, Jilian L, Geske, Jennifer R. , González, César A. , Ryn, Michelle van , Rullo, Jordan E , Griffin, Joan M. , van Ryn, Michelle, Faubion, Stephanie S. , van Ryn, Michelle , Gonzalez, Cesar , Geske, Jennifer

Mayo Clinic

Health Services Research | March 9, 2018 | Volume: 53 | Issue: 5 | Pages: 3790-3808

10.1111/1475-6773.12843 | PMID 29522236 Get It

Objectives To (1) test whether patient attitudes toward intake forms at three Midwestern outpatient clinics are significantly more negative among those who are asked to complete SOGI questions versus those who are not; and (2) gain an in‐depth understanding of patient concerns about SOGI questions. Study Setting Data were collected between 6/29/2015 and 2/29/2016 from new patients ( N = 491) who presented at three outpatient clinics in a large academic medical center. This study was originally a quality improvement project, and later, institutional review board approval was obtained for secondary data analysis. Study Design Two‐stage mixed‐methods study. (1) Experimental: New patients at three sites were randomly assigned to complete either routine intake forms (control) or routine intake forms with SOGI questions (experimental); and (2) qualitative: interviews with patients who responded negatively to SOGI questions. Principal Findings There were no significant differences in patient attitudes between experimental and control groups ( p > .05). Of those who received SOGI questions, only 3 percent reported being distressed, upset, or offended by the SOGI questions. Conclusions Collection of SOGI data as a part of the routine clinical patient intake process is not distressing to 97 percent of patients who are heterosexual, cisgender, and older than 50 years.